Clinical Trial Update: Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria [Phase 2]

View source ↗

Summary

This clinical trial update reports on the long-term safety and tolerability evaluation of HRS-5965 in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• HRS-5965

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Status: ACTIVE_NOT_RECRUITING